Current opinion in allergy and clinical immunology

Keyphrases

Publications

volume 24, number 4, 2024

Remo Poto, Corrado Pelaia, Antonio di Salvatore, Hesham Saleh, Guy W Scadding, Gilda Varricchi
Imaging of chronic rhinosinusitis with nasal polyps in the era of biological therapies. Current opinion in allergy and clinical immunology 24 (4) (2024)
Michal Ordak
Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations. Current opinion in allergy and clinical immunology 24 (4) (2024)
Daniela Carvalho
Access from healthcare professionals to evidence-based pharmacotherapy in allergy management. Current opinion in allergy and clinical immunology 24 (4) (2024)
Benedetta Biagioni, Enrico Scala, Lorenzo Cecchi
What molecular allergy teaches us about genetics and epidemiology of allergies. Current opinion in allergy and clinical immunology 24 (4) (2024)
Emeka D Ogiji, Nourah Aboheimed, Kehinde Ross, Calum Voller, Ryan Siner, Rebecca L Jensen, Carol E Jolly, Daniel F Carr
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens-Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review. Current opinion in allergy and clinical immunology 24 (4) (2024)
Remo Poto, Corrado Pelaia, Antonio di Salvatore, Hesham Saleh, Guy W Scadding, Gilda Varricchi
Imaging of chronic rhinosinusitis with nasal polyps in the era of biological therapies. Current opinion in allergy and clinical immunology 24 (4) (2024)
Remo Poto, Corrado Pelaia, Antonio di Salvatore, Hesham Saleh, Guy W Scadding, Gilda Varricchi
Imaging of chronic rhinosinusitis with nasal polyps in the era of biological therapies. Current opinion in allergy and clinical immunology 24 (4) (2024)

volume 24, number 5, 2024

Francesca Norelli, Valentina Gueli, Patrizia Bonadonna
Hymenoptera venom allergy in children and adolescents. Current opinion in allergy and clinical immunology 24 (5) (2024)
Lavinia Paternoster
Genetic landscape of atopic dermatitis. Current opinion in allergy and clinical immunology 24 (5) (2024)
Moïse Michel, Delphine Giusti, Caroline Klingebiel, Joana Vitte
Tryptase in drug-induced anaphylaxis: the need for acute and baseline values. Current opinion in allergy and clinical immunology 24 (5) (2024)
Janarthanan Ilangovan, Joana F Neves, Alexandra F Santos
Innate lymphoid cells in immunoglobulin E-mediated food allergy. Current opinion in allergy and clinical immunology 24 (5) (2024)
Mona-Rita Yacoub, Arianna Ferlito, Eustachio Nettis
Chronic urticaria: not only after COVID-19 vaccination. Current opinion in allergy and clinical immunology 24 (5) (2024)
Mona-Rita Yacoub, Arianna Ferlito, Eustachio Nettis
Chronic urticaria: not only after COVID-19 vaccination. Current opinion in allergy and clinical immunology 24 (5) (2024)
Christopher Miller, Michelle Manious, Jay Portnoy
Artificial intelligence and machine learning for anaphylaxis algorithms. Current opinion in allergy and clinical immunology 24 (5) (2024)
Janarthanan Ilangovan, Joana F Neves, Alexandra F Santos
Innate lymphoid cells in immunoglobulin E-mediated food allergy. Current opinion in allergy and clinical immunology 24 (5) (2024)
Janarthanan Ilangovan, Joana F Neves, Alexandra F Santos
Innate lymphoid cells in immunoglobulin E-mediated food allergy. Current opinion in allergy and clinical immunology 24 (5) (2024)
Erminia Ridolo, Alessandro Barone, Martina Ottoni, Francesca Nicoletta
The risk of anaphylaxis on holidays. Current opinion in allergy and clinical immunology 24 (5) (2024)
Lavinia Paternoster
Genetic landscape of atopic dermatitis. Current opinion in allergy and clinical immunology 24 (5) (2024)
Tricia Chong, Bianca Olivieri, Isabel J Skypala
Food-triggered anaphylaxis in adults. Current opinion in allergy and clinical immunology 24 (5) (2024)
Yashdeep Singh Pathania
Treatment options in refractory chronic spontaneous urticaria. Current opinion in allergy and clinical immunology 24 (5) (2024)
Atoosa Kourosh, Anil Nanda, Dipa K Sheth, Fariba Eshraghi Parmer
Integrative therapeutics for ocular surface disorders. Current opinion in allergy and clinical immunology 24 (5) (2024)
Riham Shawer, Abraham Solomon
Adverse effects of anti-cancer biologics on the ocular surface. Current opinion in allergy and clinical immunology 24 (5) (2024)
Catherine Hammond, Jay Adam Lieberman
Evidence-based use of epinephrine in anaphylaxis. Current opinion in allergy and clinical immunology 24 (5) (2024)
Anna Flts, Richard Medina, Esen K Akpek
The evolution of cyclosporine treatments for treatment of ocular surface diseases. Current opinion in allergy and clinical immunology 24 (5) (2024)
Riham Shawer, Abraham Solomon
Adverse effects of anti-cancer biologics on the ocular surface. Current opinion in allergy and clinical immunology 24 (5) (2024)
Sampson L Abu, Navpreet K Hehar, DeGaulle I Chigbu
Novel therapeutic receptor agonists and antagonists in allergic conjunctivitis. Current opinion in allergy and clinical immunology 24 (5) (2024)
Francesca Norelli, Valentina Gueli, Patrizia Bonadonna
Hymenoptera venom allergy in children and adolescents. Current opinion in allergy and clinical immunology 24 (5) (2024)
Bianca Olivieri, Gianenrico Senna, Mariana Castells
Anaphylaxis: glimpse into the future, attention to the present. Current opinion in allergy and clinical immunology 24 (5) (2024)
Christopher Miller, Michelle Manious, Jay Portnoy
Artificial intelligence and machine learning for anaphylaxis algorithms. Current opinion in allergy and clinical immunology 24 (5) (2024)
Leonard Bielory
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist. Current opinion in allergy and clinical immunology 24 (5) (2024)
Catherine Hammond, Jay Adam Lieberman
Evidence-based use of epinephrine in anaphylaxis. Current opinion in allergy and clinical immunology 24 (5) (2024)
Moïse Michel, Delphine Giusti, Caroline Klingebiel, Joana Vitte
Tryptase in drug-induced anaphylaxis: the need for acute and baseline values. Current opinion in allergy and clinical immunology 24 (5) (2024)
Gwen S Stinnett, Chuan-Hui Kuo, Santa J Ono
Impact of inflammasomes on the ocular surface. Current opinion in allergy and clinical immunology 24 (5) (2024)
Anna Flts, Richard Medina, Esen K Akpek
The evolution of cyclosporine treatments for treatment of ocular surface diseases. Current opinion in allergy and clinical immunology 24 (5) (2024)
Matthew Ryan Norris, Constance Katelaris, Nelson Rosario, Luis Delgado, Andrea Leonardi, Leonard Bielory
Ocular surface disorders: office procedures for the allergist/clinical immunologist. Current opinion in allergy and clinical immunology 24 (5) (2024)
Erminia Ridolo, Alessandro Barone, Martina Ottoni, Francesca Nicoletta
The risk of anaphylaxis on holidays. Current opinion in allergy and clinical immunology 24 (5) (2024)
Audrey Kamga, Jean Luc Bourrain, Pascal Demoly, Luciana Kase Tanno
Evidence-based data support strategies for the prevention of Hymenoptera venom anaphylaxis. Current opinion in allergy and clinical immunology 24 (5) (2024)
Gwen S Stinnett, Chuan-Hui Kuo, Santa J Ono
Impact of inflammasomes on the ocular surface. Current opinion in allergy and clinical immunology 24 (5) (2024)
Lavinia Paternoster
Genetic landscape of atopic dermatitis. Current opinion in allergy and clinical immunology 24 (5) (2024)
Matthew Ryan Norris, Constance Katelaris, Nelson Rosario, Luis Delgado, Andrea Leonardi, Leonard Bielory
Ocular surface disorders: office procedures for the allergist/clinical immunologist. Current opinion in allergy and clinical immunology 24 (5) (2024)
Yashdeep Singh Pathania
Treatment options in refractory chronic spontaneous urticaria. Current opinion in allergy and clinical immunology 24 (5) (2024)
Mona-Rita Yacoub, Arianna Ferlito, Eustachio Nettis
Chronic urticaria: not only after COVID-19 vaccination. Current opinion in allergy and clinical immunology 24 (5) (2024)
Tricia Chong, Bianca Olivieri, Isabel J Skypala
Food-triggered anaphylaxis in adults. Current opinion in allergy and clinical immunology 24 (5) (2024)
Stefania Nicola, Luca Lo Sardo, Richard Borrelli, Anna Quinternetto, Nicolò Rashidy, Luisa Brussino
Beyond the appearances: exploring complexities in anaphylaxis differential diagnosis. Current opinion in allergy and clinical immunology 24 (5) (2024)
Erminia Ridolo, Alessandro Barone, Martina Ottoni, Francesca Nicoletta
The risk of anaphylaxis on holidays. Current opinion in allergy and clinical immunology 24 (5) (2024)
Audrey Kamga, Jean Luc Bourrain, Pascal Demoly, Luciana Kase Tanno
Evidence-based data support strategies for the prevention of Hymenoptera venom anaphylaxis. Current opinion in allergy and clinical immunology 24 (5) (2024)
Atoosa Kourosh, Anil Nanda, Dipa K Sheth, Fariba Eshraghi Parmer
Integrative therapeutics for ocular surface disorders. Current opinion in allergy and clinical immunology 24 (5) (2024)
Sampson L Abu, Navpreet K Hehar, DeGaulle I Chigbu
Novel therapeutic receptor agonists and antagonists in allergic conjunctivitis. Current opinion in allergy and clinical immunology 24 (5) (2024)
Stefania Nicola, Luca Lo Sardo, Richard Borrelli, Anna Quinternetto, Nicolò Rashidy, Luisa Brussino
Beyond the appearances: exploring complexities in anaphylaxis differential diagnosis. Current opinion in allergy and clinical immunology 24 (5) (2024)
Gwen S Stinnett, Chuan-Hui Kuo, Santa J Ono
Impact of inflammasomes on the ocular surface. Current opinion in allergy and clinical immunology 24 (5) (2024)